See also this year's filing and all EDGAR filings for this company.
PDF Report 0001560241_2020_G1_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001560241, G1 Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 271,003,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,538,000 |
| 3 | remainder_Assets | 10,290,000 |
| 4 | LiabilitiesCurrent | 19,769,000 |
| 5 | LiabilitiesNoncurrent | 9,535,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 40,039,000 |
| 9 | ResearchAndDevelopmentExpense | 89,002,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 6,594,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 284,831,000 |
| 1 | Liabilities | 29,304,000 |
| 2 | Expenses | 129,041,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 255,527,000 |
| 5 | NetIncome | -122,447,000 |
| 6 | ComprehensiveNetIncome | -122,447,000 |
| 7 | BaseVar | 224,885,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.77 |
| 9 | EconomicCapitalRatio | 3.53 |
Edgar->Model Mapping
Feature Distribution
Change over Time
